(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AP1S2 mRNA] CTD PMID:31150632 (-)-demecolcine decreases expression ISO AP1S2 (Homo sapiens) 6480464 Demecolcine results in decreased expression of AP1S2 mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions ISO Ap1s2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AP1S2 mRNA CTD PMID:36331819 1,1-dichloroethene increases expression ISO Ap1s2 (Mus musculus) 6480464 vinylidene chloride results in increased expression of AP1S2 mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of AP1S2 mRNA CTD PMID:25380136 17beta-estradiol increases expression ISO AP1S2 (Homo sapiens) 6480464 Estradiol results in increased expression of AP1S2 mRNA CTD PMID:16474171 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AP1S2 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AP1S2 mRNA CTD PMID:32741896 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO AP1S2 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of AP1S2 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO AP1S2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of AP1S2 mRNA CTD PMID:17101203 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of AP1S2 mRNA CTD PMID:32109520 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ap1s2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of AP1S2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ap1s2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of AP1S2 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO AP1S2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of AP1S2 mRNA CTD PMID:11489354 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-methylcholine affects expression ISO AP1S2 (Homo sapiens) 6480464 beta-methylcholine affects the expression of AP1S2 mRNA CTD PMID:21179406 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO AP1S2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of AP1S2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AP1S2 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of AP1S2 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane decreases expression ISO Ap1s2 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of AP1S2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO AP1S2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of AP1S2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO Ap1s2 (Mus musculus) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of AP1S2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO Ap1s2 (Mus musculus) 6480464 Fenretinide results in increased expression of AP1S2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO AP1S2 (Homo sapiens) 6480464 Decitabine affects the expression of AP1S2 mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine increases expression ISO AP1S2 (Homo sapiens) 6480464 Decitabine results in increased expression of AP1S2 mRNA CTD PMID:19194470 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of AP1S2 mRNA CTD PMID:24780913 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of AP1S2 mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO AP1S2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of AP1S2 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO AP1S2 (Homo sapiens) 6480464 Tretinoin results in increased expression of AP1S2 mRNA CTD PMID:15498508 all-trans-retinoic acid decreases expression ISO AP1S2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of AP1S2 mRNA CTD PMID:21934132 and PMID:23724009 amitrole increases expression EXP 6480464 Amitrole results in increased expression of AP1S2 mRNA CTD PMID:30047161 antirheumatic drug decreases expression ISO AP1S2 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of AP1S2 mRNA CTD PMID:24449571 benzo[a]pyrene increases expression ISO Ap1s2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of AP1S2 mRNA CTD PMID:27195522 benzo[a]pyrene decreases methylation ISO AP1S2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of AP1S2 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO AP1S2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of AP1S2 5' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I increases expression ISO AP1S2 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 bisphenol A increases expression ISO AP1S2 (Homo sapiens) 6480464 bisphenol A results in increased expression of AP1S2 mRNA CTD PMID:16474171 bisphenol A increases expression ISO Ap1s2 (Mus musculus) 6480464 bisphenol A results in increased expression of AP1S2 mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO AP1S2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AP1S2 mRNA CTD PMID:28628672 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of AP1S2 mRNA CTD PMID:25181051 bisphenol F increases expression ISO Ap1s2 (Mus musculus) 6480464 bisphenol F results in increased expression of AP1S2 mRNA CTD PMID:30951980 butanal increases expression ISO AP1S2 (Homo sapiens) 6480464 butyraldehyde results in increased expression of AP1S2 mRNA CTD PMID:26079696 carmustine affects response to substance ISO AP1S2 (Homo sapiens) 6480464 AP1S2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 CGP 52608 multiple interactions ISO AP1S2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to AP1S2 gene] CTD PMID:28238834 choline multiple interactions ISO Ap1s2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AP1S2 mRNA CTD PMID:20938992 cisplatin increases expression ISO AP1S2 (Homo sapiens) 6480464 Cisplatin results in increased expression of AP1S2 mRNA CTD PMID:27594783 cisplatin affects expression ISO AP1S2 (Homo sapiens) 6480464 Cisplatin affects the expression of AP1S2 mRNA CTD PMID:23300844 crocidolite asbestos decreases expression ISO Ap1s2 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of AP1S2 mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO AP1S2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of AP1S2 mRNA CTD PMID:25562108 and PMID:27989131 cylindrospermopsin decreases expression ISO AP1S2 (Homo sapiens) 6480464 cylindrospermopsin results in decreased expression of AP1S2 mRNA CTD PMID:24921660 dexamethasone multiple interactions ISO AP1S2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of AP1S2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AP1S2 mRNA CTD PMID:28628672 dibutyl phthalate increases expression ISO Ap1s2 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of AP1S2 mRNA CTD PMID:17361019 and PMID:21266533 diuron decreases expression EXP 6480464 Diuron results in decreased expression of AP1S2 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO AP1S2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of AP1S2 mRNA CTD PMID:29391264 ethanol decreases expression ISO Ap1s2 (Mus musculus) 6480464 Ethanol results in decreased expression of AP1S2 mRNA CTD PMID:19167417 ethanol affects expression ISO Ap1s2 (Mus musculus) 6480464 Ethanol affects the expression of AP1S2 mRNA CTD PMID:26730594 folic acid multiple interactions ISO Ap1s2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AP1S2 mRNA CTD PMID:20938992 formaldehyde decreases expression ISO AP1S2 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of AP1S2 mRNA CTD PMID:23649840 furan increases methylation EXP 6480464 furan results in increased methylation of AP1S2 gene CTD PMID:22079235 furan increases expression EXP 6480464 furan results in increased expression of AP1S2 mRNA CTD PMID:27387713 genistein increases expression ISO AP1S2 (Homo sapiens) 6480464 Genistein results in increased expression of AP1S2 mRNA CTD PMID:16474171 indometacin multiple interactions ISO AP1S2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of AP1S2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AP1S2 mRNA CTD PMID:28628672 isobutanol multiple interactions ISO AP1S2 (Homo sapiens) 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of AP1S2 mRNA CTD PMID:29432896 L-methionine multiple interactions ISO Ap1s2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of AP1S2 mRNA CTD PMID:20938992 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of AP1S2 mRNA CTD PMID:30467583 methimazole increases expression EXP 6480464 Methimazole results in increased expression of AP1S2 mRNA CTD PMID:30047161 methyl methanesulfonate decreases expression ISO AP1S2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of AP1S2 mRNA CTD PMID:23649840 methylparaben decreases expression ISO AP1S2 (Homo sapiens) 6480464 methylparaben results in decreased expression of AP1S2 mRNA CTD PMID:31745603 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of AP1S2 mRNA CTD PMID:25380136 paracetamol increases expression ISO AP1S2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of AP1S2 mRNA CTD PMID:21420995 and PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of AP1S2 mRNA CTD PMID:33387578 paracetamol affects expression ISO AP1S2 (Homo sapiens) 6480464 Acetaminophen affects the expression of AP1S2 mRNA CTD PMID:25458485 perfluorooctane-1-sulfonic acid multiple interactions ISO Ap1s2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AP1S2 mRNA CTD PMID:36331819 phenobarbital affects expression ISO Ap1s2 (Mus musculus) 6480464 Phenobarbital affects the expression of AP1S2 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO AP1S2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of AP1S2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO AP1S2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 pioglitazone decreases expression ISO AP1S2 (Homo sapiens) 6480464 Pioglitazone results in decreased expression of AP1S2 mRNA CTD PMID:30031879 pirinixic acid decreases expression ISO Ap1s2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of AP1S2 mRNA CTD PMID:20813756 quercetin increases expression ISO AP1S2 (Homo sapiens) 6480464 Quercetin results in increased expression of AP1S2 mRNA CTD PMID:30152185 SB 431542 multiple interactions ISO AP1S2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO AP1S2 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of AP1S2 mRNA CTD PMID:25895662 silver atom decreases expression ISO Ap1s2 (Mus musculus) 6480464 Silver results in decreased expression of AP1S2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO Ap1s2 (Mus musculus) 6480464 Silver results in decreased expression of AP1S2 mRNA CTD PMID:27131904 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of AP1S2 mRNA CTD PMID:27257137 tamibarotene increases expression ISO AP1S2 (Homo sapiens) 6480464 tamibarotene results in increased expression of AP1S2 mRNA CTD PMID:15498508 temozolomide affects response to substance ISO AP1S2 (Homo sapiens) 6480464 AP1S2 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 temozolomide increases expression ISO AP1S2 (Homo sapiens) 6480464 Temozolomide results in increased expression of AP1S2 mRNA CTD PMID:31758290 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of AP1S2 mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO Ap1s2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of AP1S2 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AP1S2 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of AP1S2 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of AP1S2 mRNA CTD PMID:23411599 and PMID:34492290 trichostatin A decreases expression ISO AP1S2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of AP1S2 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO AP1S2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AP1S2 mRNA CTD PMID:27188386 tris(2-butoxyethyl) phosphate affects expression ISO AP1S2 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of AP1S2 mRNA CTD PMID:29024780 valproic acid decreases expression ISO Ap1s2 (Mus musculus) 6480464 Valproic Acid results in decreased expression of AP1S2 mRNA CTD PMID:15799026 valproic acid increases expression ISO AP1S2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of AP1S2 mRNA CTD PMID:28001369 valproic acid affects expression ISO AP1S2 (Homo sapiens) 6480464 Valproic Acid affects the expression of AP1S2 mRNA CTD PMID:23179753 valproic acid decreases expression ISO AP1S2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of AP1S2 mRNA CTD PMID:24935251 more ... valproic acid multiple interactions ISO AP1S2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AP1S2 mRNA CTD PMID:27188386 vincristine decreases expression ISO AP1S2 (Homo sapiens) 6480464 Vincristine results in decreased expression of AP1S2 mRNA CTD PMID:23649840 zoledronic acid increases expression ISO AP1S2 (Homo sapiens) 6480464 zoledronic acid results in increased expression of AP1S2 mRNA CTD PMID:24714768